Boulder, CO, United States of America

James Collier


 

Average Co-Inventor Count = 18.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations of James Collier: Pioneering the Future of RET Kinase Inhibition

Introduction

James Collier, an accomplished inventor based in Boulder, Colorado, has made significant contributions to the field of biochemistry, particularly in the development of innovative compounds for therapeutic applications. With a total of five patents to his name, Collier's work focuses on addressing critical medical needs related to RET kinase-associated diseases.

Latest Patents

Among his latest innovations are the patents for substituted pyrazolo[1,5-A]pyridine compounds, which serve as inhibitors of RET kinase. These compounds are crucial in the treatment and prevention of various diseases and disorders associated with RET kinase activity. The patent documents detail the specific chemical formulas, including the meanings attributed to the components of the compounds, underscoring the complexity and precision of his research.

Career Highlights

Collier's professional journey has been marked by his role at Array Biopharma Inc., where he has significantly impacted the pharmaceutical landscape. His expertise in developing novel inhibitors has positioned him as a respected figure within the industry, contributing to advancements that may lead to improved therapeutic strategies.

Collaborations

Throughout his career, Collier has collaborated with notable professionals, including Steven Wade Andrews and Sean Douglas Aronow. These partnerships have not only enhanced his research outcomes but also fostered a collaborative environment that encourages innovative thinking and problem-solving.

Conclusion

James Collier's dedication to innovation and invention in the realm of pharmacology is evident through his impactful patents and collaborative efforts. By focusing on RET kinase inhibitors, he is paving the way for new treatments that hold promise for individuals affected by RET-associated diseases. His work exemplifies the vital role inventors play in advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…